US Stock MarketDetailed Quotes

SRRK Scholar Rock

Watchlist
  • 37.070
  • -0.560-1.49%
Close Feb 14 16:00 ET
  • 35.020
  • -2.050-5.53%
Pre 04:00 ET
3.47BMarket Cap-15.71P/E (TTM)

About Scholar Rock Company

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.

Company Profile

SymbolSRRK
Company NameScholar Rock
Listing DateMay 24, 2018
Issue Price14.00
Founded2012
CEODr. Jay T. Backstrom, M.D.,M.P.H.
MarketNASDAQ
Employees150
Fiscal Year Ends12-31
Address301 Binney Street,3rd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-259-3860

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay T. Backstrom, M.D.,M.P.H.
  • Director, President and Chief Executive Officer
  • 4.11M
  • Dr. Jing L. Marantz, M.D.,PhD
  • Chief Medical Officer
  • --
  • Tracey Sacco
  • Chief Commercial Officer
  • 2.28M
  • Caryn Parlavecchio
  • Chief Human Resources Officer
  • --
  • Edward H. Myles
  • Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
  • 2.01M
  • Lisa Wyman
  • Chief Technical and Quality Officer
  • --
  • Mohammed Qatanani
  • Chief Scientific Officer
  • --
  • David L. Hallal
  • Chairman of the Board
  • 416.70K
  • Michael Gilman, PhD
  • Independent Director
  • 299.20K
  • Dr. Srinivas Akkaraju, M.D.,PhD
  • Independent Director
  • 291.23K
  • Richard H. Brudnick
  • Independent Director
  • 367.96K
  • Dr. Akshay K. Vaishnaw, M.D.,PhD
  • Independent Director
  • 298.20K
  • Kristina M. Burow
  • Independent Director
  • 300.34K
  • Katie Peng
  • Independent Director
  • --
  • Joshua Reed
  • Independent Director
  • 305.70K
  • Dr. Jeffrey S. Flier, M.D.
  • Independent Director
  • 305.70K
  • Junlin Ho
  • General Counsel and Corporate Secretary
  • --

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More